Taiwan · Delayed Price · Currency is TWD ICARES Medicus Statistics
Total Valuation
ICARES Medicus has a market cap or net worth of TWD 3.46 billion. The enterprise value is 3.66 billion.
| Market Cap | 3.46B |
| Enterprise Value | 3.66B |
Important Dates
The next estimated earnings date is Thursday, March 12, 2026.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
ICARES Medicus has 47.38 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 47.38M |
| Shares Outstanding | 47.38M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 21.23% |
| Owned by Institutions (%) | 0.25% |
| Float | 23.18M |
Valuation Ratios
The trailing PE ratio is 54.39.
| PE Ratio | 54.39 |
| Forward PE | n/a |
| PS Ratio | 3.18 |
| PB Ratio | 1.83 |
| P/TBV Ratio | 3.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 135.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.64, with an EV/FCF ratio of -32.55.
| EV / Earnings | 57.80 |
| EV / Sales | 3.37 |
| EV / EBITDA | 12.64 |
| EV / EBIT | 24.04 |
| EV / FCF | -32.55 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.94 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | -8.07 |
| Interest Coverage | 5.99 |
Financial Efficiency
Return on equity (ROE) is 0.94% and return on invested capital (ROIC) is 3.39%.
| Return on Equity (ROE) | 0.94% |
| Return on Assets (ROA) | 2.97% |
| Return on Invested Capital (ROIC) | 3.39% |
| Return on Capital Employed (ROCE) | 6.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 64 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, ICARES Medicus has paid 70.37 million in taxes.
| Income Tax | 70.37M |
| Effective Tax Rate | 80.63% |
Stock Price Statistics
The stock price has decreased by -26.08% in the last 52 weeks. The beta is 0.38, so ICARES Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -26.08% |
| 50-Day Moving Average | 80.84 |
| 200-Day Moving Average | 96.75 |
| Relative Strength Index (RSI) | 59.61 |
| Average Volume (20 Days) | 33,314 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICARES Medicus had revenue of TWD 1.09 billion and earned 63.38 million in profits. Earnings per share was 1.34.
| Revenue | 1.09B |
| Gross Profit | 650.46M |
| Operating Income | 143.97M |
| Pretax Income | 87.27M |
| Net Income | 63.38M |
| EBITDA | 243.69M |
| EBIT | 143.97M |
| Earnings Per Share (EPS) | 1.34 |
Balance Sheet
The company has 842.92 million in cash and 908.54 million in debt, with a net cash position of -65.62 million or -1.38 per share.
| Cash & Cash Equivalents | 842.92M |
| Total Debt | 908.54M |
| Net Cash | -65.62M |
| Net Cash Per Share | -1.38 |
| Equity (Book Value) | 1.89B |
| Book Value Per Share | 36.94 |
| Working Capital | 814.03M |
Cash Flow
In the last 12 months, operating cash flow was 25.45 million and capital expenditures -137.98 million, giving a free cash flow of -112.53 million.
| Operating Cash Flow | 25.45M |
| Capital Expenditures | -137.98M |
| Free Cash Flow | -112.53M |
| FCF Per Share | -2.37 |
Margins
Gross margin is 59.82%, with operating and profit margins of 13.24% and 5.83%.
| Gross Margin | 59.82% |
| Operating Margin | 13.24% |
| Pretax Margin | 8.03% |
| Profit Margin | 5.83% |
| EBITDA Margin | 22.41% |
| EBIT Margin | 13.24% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | 65.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 20.39% |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.07% |
| Earnings Yield | 1.83% |
| FCF Yield | -3.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 22, 2025. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 22, 2025 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
ICARES Medicus has an Altman Z-Score of 3.47 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.47 |
| Piotroski F-Score | 5 |